Elevated serum neopterin levels in acetaminophen-induced liver injury. 2011

Seref Demirbas, and Erdinc Cakir, and Emin Ozgur Akgul, and Melik Seyrek, and Tuncer Cayci, and Yasemin Gulcan Kurt, and Bulent Uysal, and Ibrahim Aydin, and Bulent Kurt, and Halil Yaman, and Mehmet Kemal Erbil
Department of Internal Medicine, Gulhane Military Medical Academy, 06018 Etlik, Ankara, Turkey.

Neopterin is synthesized in macrophage/Kupffer cells by interferon-gamma and other cytokines. This study aimed to evaluate the utility of using neopterin as a biomarker of acetaminophen (APAP)-induced liver injury. Wistar rats, randomly divided into two groups (APAP and normal), received APAP (1.0 g/kg) and distilled water, respectively, by gastric tube. The APAP group had a higher degree of liver necrosis than the control group. The APAP group also had significantly higher serum neopterin levels than the normal group. Serum neopterin levels correlated with serum AST, ALT activities, and degree of necrosis. This study demonstrates the preclinical utility of neopterin as a biomarker for the animal model of APAP-induced liver injury. Further research studies are required to determine the preclinical opportunities of using neopterin as a marker of APAP-induced liver injury.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008297 Male Males
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D000082 Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage. Acetamidophenol,Hydroxyacetanilide,Paracetamol,APAP,Acamol,Acephen,Acetaco,Acetominophen,Algotropyl,Anacin-3,Datril,N-(4-Hydroxyphenyl)acetanilide,N-Acetyl-p-aminophenol,Panadol,Tylenol,p-Acetamidophenol,p-Hydroxyacetanilide,Anacin 3,Anacin3
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Seref Demirbas, and Erdinc Cakir, and Emin Ozgur Akgul, and Melik Seyrek, and Tuncer Cayci, and Yasemin Gulcan Kurt, and Bulent Uysal, and Ibrahim Aydin, and Bulent Kurt, and Halil Yaman, and Mehmet Kemal Erbil
January 1986, Lung,
Seref Demirbas, and Erdinc Cakir, and Emin Ozgur Akgul, and Melik Seyrek, and Tuncer Cayci, and Yasemin Gulcan Kurt, and Bulent Uysal, and Ibrahim Aydin, and Bulent Kurt, and Halil Yaman, and Mehmet Kemal Erbil
August 1991, Atherosclerosis,
Seref Demirbas, and Erdinc Cakir, and Emin Ozgur Akgul, and Melik Seyrek, and Tuncer Cayci, and Yasemin Gulcan Kurt, and Bulent Uysal, and Ibrahim Aydin, and Bulent Kurt, and Halil Yaman, and Mehmet Kemal Erbil
January 1989, Journal of biological regulators and homeostatic agents,
Seref Demirbas, and Erdinc Cakir, and Emin Ozgur Akgul, and Melik Seyrek, and Tuncer Cayci, and Yasemin Gulcan Kurt, and Bulent Uysal, and Ibrahim Aydin, and Bulent Kurt, and Halil Yaman, and Mehmet Kemal Erbil
December 2013, Alimentary pharmacology & therapeutics,
Seref Demirbas, and Erdinc Cakir, and Emin Ozgur Akgul, and Melik Seyrek, and Tuncer Cayci, and Yasemin Gulcan Kurt, and Bulent Uysal, and Ibrahim Aydin, and Bulent Kurt, and Halil Yaman, and Mehmet Kemal Erbil
March 2017, Hepatology (Baltimore, Md.),
Seref Demirbas, and Erdinc Cakir, and Emin Ozgur Akgul, and Melik Seyrek, and Tuncer Cayci, and Yasemin Gulcan Kurt, and Bulent Uysal, and Ibrahim Aydin, and Bulent Kurt, and Halil Yaman, and Mehmet Kemal Erbil
September 1993, Drug and alcohol dependence,
Seref Demirbas, and Erdinc Cakir, and Emin Ozgur Akgul, and Melik Seyrek, and Tuncer Cayci, and Yasemin Gulcan Kurt, and Bulent Uysal, and Ibrahim Aydin, and Bulent Kurt, and Halil Yaman, and Mehmet Kemal Erbil
January 1995, Clinical and experimental rheumatology,
Seref Demirbas, and Erdinc Cakir, and Emin Ozgur Akgul, and Melik Seyrek, and Tuncer Cayci, and Yasemin Gulcan Kurt, and Bulent Uysal, and Ibrahim Aydin, and Bulent Kurt, and Halil Yaman, and Mehmet Kemal Erbil
April 1992, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Seref Demirbas, and Erdinc Cakir, and Emin Ozgur Akgul, and Melik Seyrek, and Tuncer Cayci, and Yasemin Gulcan Kurt, and Bulent Uysal, and Ibrahim Aydin, and Bulent Kurt, and Halil Yaman, and Mehmet Kemal Erbil
June 1997, British journal of rheumatology,
Seref Demirbas, and Erdinc Cakir, and Emin Ozgur Akgul, and Melik Seyrek, and Tuncer Cayci, and Yasemin Gulcan Kurt, and Bulent Uysal, and Ibrahim Aydin, and Bulent Kurt, and Halil Yaman, and Mehmet Kemal Erbil
January 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Copied contents to your clipboard!